Vehicle Recompete: CRO SUPPORT FOR NCATS REGULATORY AFFAIRS AND RELATED SERVICES — INDEFINITE DELIVERY / INDEFINITE QUANTITY 75N95021R00008
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This indefinite delivery, indefinite quantity contract provides contract research organization support for regulatory affairs and related services for the National Institutes of Health. The vehicle, which has an ordering period extending through June 9, 2027, is currently classified as a full recompete. There are currently seven active task orders with a combined total value of 1,107,403.33 dollars. Two companies currently hold orders under this vehicle, with CCS Associates, Inc. managing four orders totaling 741,425.07 dollars and MPF Federal, LLC managing three orders totaling 365,978.26 dollars. Primary activities focus on regulatory support for gene therapy candidates and the preparation of Investigational New Drug and Pre-Investigational New Drug applications with the Food and Drug Administration for various treatments, including those for Jansen's Metaphyseal Chondrodysplasia and Congenital Myasthenic Syndromes.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
3 awards under one solicitation: 75N95022D00013, 75N95022D00014, 75N95022D00015 Original Solicitation: 75N95021R00008 Agencies: National Institutes of Health Classification: full-recompete (Confidence: high - 85/100)
Incumbents (2 companies hold orders on this vehicle): - CCS ASSOCIATES, INC.: $741,425.07 across 4 orders - MPF FEDERAL, LLC: $365,978.26 across 3 orders
Top task orders by value: - PREPARATION OF AN INVESTIGATIONAL NEW DRUG (IND) APPLICATION WITH FOOD AND DRUG ADMINISTRATION (FDA) FOR A TREATMENT FOR JANSEN'S METAPHYSEAL CHONDRODYSPLASIA ($240,897.48) - CCS ASSOCIATES, INC. - NEW SOW FOR REGULATORY ACTIVITIES FOR PCCA AND MMAB GENE THERAPY PRODUCTS ($230,616.68) - CCS ASSOCIATES, INC. - REGULATORY SUPPORT FOR LEAD GENE THERAPY CANDIDATES AS A TREATMENT FOR ORGANIC ACIDEMIAS, PROPIONIC ACIDEMIA (PA) AND METHYLMALONIC ACIDEMIA TYPE B (MMAB) ($178,885.25) - MPF FEDERAL, LLC - REGULATORY SUPPORT FOR LEAD GENE THERAPY CANDIDATES AS A TREATMENT FOR CONGENITAL MYASTHENIC SYNDROMES ($159,115.55) - CCS ASSOCIATES, INC. - REGULATORY SUPPORT FOR PREPARATION AND FILING OF A PRE-INVESTIGATIONAL NEW DRUG (PRE-IND) APPLICATION WITH THE FOOD AND DRUG ADMINISTRATION (FDA) FOR CLINICAL DEVELOPMENT OF MITRAGYNINE (MG). ($110,795.36) - CCS ASSOCIATES, INC.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → National Institutes of Health
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
